Dacarbazine
Dacarbazine for Injection, USP
Approved
Approval ID
26e91082-7698-4680-beab-07c47802f0f9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 28, 2020
Manufacturers
FDA
Teva Parenteral Medicines, Inc.
DUNS: 794362533
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dacarbazine
PRODUCT DETAILS
NDC Product Code0703-5075
Application NumberANDA075259
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 28, 2020
Generic NameDacarbazine
INGREDIENTS (3)
DACARBAZINEActive
Quantity: 200 mg in 20 mL
Code: 7GR28W0FJI
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT